bNovate Technologies is a technology company.
bNovate Technologies has raised $13.0M across 1 funding round.
bNovate Technologies has raised $13.0M in total across 1 funding round.
bNovate Technologies has raised $13.0M in total across 1 funding round.
bNovate Technologies's investors include Emerald Technology Ventures.
bNovate Technologies SA is a Swiss technology company founded in 2011 that develops automated, real-time microbiological water monitoring solutions using flow cytometry technology.[1][2][3] Its flagship product, BactoSense, is an IoT-connected device that detects bacteria in drinking water in 20 minutes, serving municipal water utilities, industrial clients in food/beverage/pharma, and environmental sectors to prevent contamination and ensure compliance.[1][2][4] With over 40 employees, 300+ units installed across 100+ customers mainly in Europe, and recent expansions into the US, UK, and Germany, bNovate demonstrates strong growth momentum, including awards like the 2023 World Economic Forum Global Freshwater Challenge.[1][3]
The company addresses critical delays in traditional lab testing (1-5 days) by providing near-real-time data for treatment and distribution systems, aligning with UN SDG #6 for safe water access.[1][6]
bNovate Technologies SA was co-founded in 2011 in Lausanne, Switzerland, by Prof. Dr. Peter Ryser (Chairman), Dr. Simon Künzi (Vice-Chairman), and Dr. Fabrice Merenda (now Head of R&D), emerging from a project at École Polytechnique Fédérale de Lausanne (EPFL).[2][3] The idea stemmed from advancing automated analysis instruments for rapid bacterial detection in water, leveraging the founders' expertise in microbiology, engineering, and photonics.[3]
Early traction built through milestones: BactoSense launched commercially in 2017 for drinking water, followed by AQU@Sense MB in 2018 for pharma, BactoSense Multi in 2022 for food/beverage, and international growth including a 2020 Zürich office and 2024 US entry under new CEO Serge Gander.[3] Pivotal wins like the 2019 SME Water Europe Innovation Award and 2023 WEF challenge solidified its path from EPFL spinout to global player with 300+ installations.[1][3]
bNovate rides the wave of digital water management and IoT for sustainability, addressing global water safety amid climate pressures, urbanization, and stricter regulations on microbial risks.[4][6] Timing is ideal with rising demand for real-time monitoring in aging infrastructure and UN SDG #6 priorities, where traditional methods fail.[1][6]
Market forces like water scarcity (affecting 2B+ people) and industry needs in pharma/food favor its tech, influencing the ecosystem by enabling predictive analytics, reducing waste, and partnering with bodies like WEF and Sustainable Switzerland.[3][6] As a Swiss biotech leader, it pushes flow cytometry from labs to field-deployed IoT, democratizing safe water data.
bNovate is poised for accelerated global expansion, building on 2024 US entry and AI-enhanced products to target North America and Asia amid booming smart water markets.[3] Trends like AI-driven predictive maintenance and regulatory pushes for real-time monitoring will shape its trajectory, potentially scaling to 1,000+ units.
Its influence may evolve from European niche leader to key enabler of digital water safety worldwide, reinforcing the mission of safe water, anytime, anywhere through sustained innovation.[6]
bNovate Technologies has raised $13.0M across 1 funding round. Most recently, it raised $13.0M Series C in June 2023.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Jun 1, 2023 | $13.0M Series C | Emerald Technology Ventures |